G. Hoermannsperger

Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease

D. Haller, M. Blaut, G. Duncan, 2009, Inflammatory bowel diseases.

Post-Translational Inhibition of IP-10 Secretion in IEC by Probiotic Bacteria: Impact on Chronic Inflammation

D. Haller, M. Blaut, T. Clavel, 2009, PloS one.

Safety assessment of probiotics for human use

J. Heimbach, D. Haller, L. Akkermans, 2010, Gut microbes.